Gil, Roger

X–linked spastic paraplegia and Pelizaeus–Merzbacher disease are allelic disorders at the proteolipid protein locus

Saugier-Veber, P., Munnich, A., Bonneau, D., Rozet, J.-M., Le Merrer, M., Gil, R., & Boespflug-Tanguy, O. (1994) · Nature Genetics

Hereditary Neurological DisordersMultiple Sclerosis Research Studies

Cited by 359

mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease

Lafay‐Chebassier, C., Paccalin, M., Page, G., Barc‐Pain, S., Perault‐Pochat, M. C., Gil, R., Pradier, L., & Hugon, J. (2005) · Journal of Neurochemistry

Alzheimer's disease research and treatmentsPI3K/AKT/mTOR signaling in cancer

Cited by 211

Activated mTOR and PKR Kinases in Lymphocytes Correlate with Memory and Cognitive Decline in Alzheimer’s Disease

Paccalin, M., Pain-Barc, S., Pluchon, C., Paul, C., Besson, M.-N., Carret-Rebillat, A.-S., Rioux-Bilan, A., Gil, R., & Hugon, J. (2006) · Dementia and Geriatric Cognitive Disorders

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 96

Forgetting What You Have Checked: A Link Between Working Memory Impairment and Checking Behaviors in Obsessive-Compulsive Disorder

Jaafari, N., Frasca, M., Rigalleau, F., Rachid, F., Gil, R., Olié, J.-P., Guehl, D., Burbaud, P., Aouizerate, B., Rotgé, J.-Y., et al. (2013) · European Psychiatry

Obsessive-Compulsive Spectrum DisordersPsychoanalysis and Psychopathology Research

Cited by 58

The immunosuppressant rapamycin exacerbates neurotoxicity of Aβ peptide

Lafay‐Chebassier, C., Pérault‐Pochat, M. C., Page, G., Bilan, A. R., Damjanac, M., Pain, S., Houeto, J., Gil, R., & Hugon, J. (2006) · Journal of Neuroscience Research

Alzheimer's disease research and treatmentsPI3K/AKT/mTOR signaling in cancer

Cited by 52

Evidence of molecular links between PKR and mTOR signalling pathways in Aβ neurotoxicity: Role of p53, Redd1 and TSC2

Morel, M., Couturier, J., Pontcharraud, R., Gil, R., Fauconneau, B., Paccalin, M., & Page, G. (2009) · Neurobiology of Disease

Alzheimer's disease research and treatmentsPI3K/AKT/mTOR signaling in cancer

Cited by 36

PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients

Damjanac, M., Page, G., Ragot, S., Laborie, G., Gil, R., Hugon, J., & Paccalin, M. (2009) · Journal of Cellular and Molecular Medicine

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 31